Prostarm Approves ₹43.27 Crore Preferential Warrant Issue For Non-Promoters

Q1 FY27 Consolidated Results YoY: Revenue at 76.0 Cr vs 54.9 Cr, up 38.5%. EBITDA at 9.0 Cr vs 4.7 Cr, up 90.5%. EBITDA Margin at 11.9% vs 8.6%, expansion of 320bps. PAT at 4.6 Cr vs 1.8 Cr, up 150.5%. Cost of materials grew 113.9% vs revenue growth of 38.5%; Other Income rose to 2.5 Cr from 0.8 Cr, up 203.1%. Board approved preferential issue of warrants aggregating up to 43.3 Cr, potentially increasing equity shares by 5.0%. Commencement of relocated operations was delayed pending regulatory approval, now expected by September 30, 2026.